The effects of aspirin and ticagrelor on infection-mediated platelet activation in healthy volunteers.

Phase 4

Completed

• Conditions: Acute coronary syndrome; Cardiovascular - Coronary heart disease; Blood - Normal development and function of platelets and erythrocytes

• Registration Number: ACTRN12616001508460
• Lead Sponsor: Kathryn Hally

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Healthy, aged between 45 and 65

Exclusion Criteria

i) known cardiovascular or inflammatory disease,
ii) platelet function disorder,
iii) a platelet count of less than 100x109/L,
iv) taken any anti-platelet, non-steroidal anti-inflammatory drugs or any cardiovascular or immune-modulating medication within 7 days prior to recruitment,
v) acute illness within 6 weeks prior to recruitment,
vi) pregnancy,
vii) diabetes mellitus,
viii) inability to provide written informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified